California Governor vs Chevron Debate Over Branded Gas Value Heats Up
SpaceX Scrubs Starship V3 Test Flight Reschedules for Friday IPO Filing Reveals 15 Billion Program Cost
Nios LongTerm Growth Potential Possibility of Doubling by 2029
CoveredCall ETF MSTY Limited Upside Potential Full Downside Exposure
States Escalate Legal Battle Against Prediction Markets as Regulatory Clash Intensifies
Anthropic Cofounder Chris Olah Warns Vatican on AI Job Losses Calls for Moral Oversight
SPIR Q1 2026 Earnings EPS Misses Estimates as Stock Surges 1224
AVR Q1 2026 Earnings Wider Than Expected Losses as PreRevenue Biotech Advances
JACK Q1 2026 Earnings EPS Misses by a Hair as Stock Rises 176
ZTO Q1 2026 Earnings Strong EPS Reported Amid Limited Disclosures
MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline
MNST Q1 2026 Earnings Earnings Beat Estimates as EPS Surprises 833
Lexaria Bioscience LEXX Surges 733 as Biotech Momentum Builds Key Levels in Focus
Evaxion EVAX Edges Higher Amid Biotech Sector Volatility Support and Resistance Levels in Focus
Pitney Bowes PBI Edges Higher as Stock Holds Key Support Zone
Berto Acquisition Corp TACO Edges Higher Amid Quiet Trading Support and Resistance Levels in Focus
Graham Corporation GHM Holds Near Support as Slight Decline Tests Key Levels
MTX Q1 2026 Earnings EPS Beats Estimates by 887 as Shares Edge Higher
Grand Canyon Education LOPE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher
PLG Q4 2023 Earnings NarrowerThanExpected Loss Amid Exploration Progress
CYCN Q4 2025 Earnings Narrowed Losses Exceed Expectations as Development Programs Progress
PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability
Lucid Diagnostics Inc Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Diagnostics Firm Advances Product Commercialization
Vickers Top Insider Picks Signal Potential Confidence Amid Market Volatility
FOXF Q1 2026 Earnings EPS Beats Estimates by 1153 Amid Cost Discipline
Permian Resources Holds Steady After Minor Decline Key Levels in Focus